S. Bettinger

发表

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.

Gary Middleton, Takayuki Yoshino, Chloe E Atreya, 2018, Cancer discovery.

A randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATForM).

D. Schadendorf, P. Ascierto, A. Boran, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010.

R. Ramlau, J. Limacher, E. Quoix, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.